Study of immune response in early sepsis or septic shock
Part of Immune system & allergy, Infections clinical trials.
This trial looks at how the immune system behaves in the first day after septic shock begins. It may help researchers find better ways to support the body’s immune balance during sepsis, but you must be enrolled very quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sepsis or septic shock (using SEPSIS-3 criteria)
- You are 18 years of age or older
- You can (or your legal representative can) give informed consent to join
- You are enrolled within 24 hours of septic shock starting/being diagnosed
- You do not have an immune system disorder from before (immunodeficiency)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how sepsis (a severe infection) affects the immune system. The goal is to see if certain blood markers can help doctors predict recovery, which could improve the care of future patients with septic shock.
This study looks at how the immune system changes during sepsis, a life-threatening infection that can cause organ failure. By studying blood samples over time, researchers hope to find better ways to treat or prevent complications.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at abnormal immune cells (from the bone marrow) in people with sepsis or severe trauma with shock. It aims to understand why the body’s immune response gets out of balance, which could help guide future treatments.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.